Annual report pursuant to Section 13 and 15(d)

Capital Deficiency (Details Narrative)

v2.4.0.6
Capital Deficiency (Details Narrative) (USD $)
Sep. 28, 2012
Jul. 03, 2012
Jun. 28, 2012
Apr. 25, 2012
Mar. 01, 2012
Jan. 11, 2012
Nov. 30, 2011
Nov. 29, 2011
Nov. 03, 2011
Oct. 29, 2011
Sep. 21, 2011
May 16, 2011
Equity [Abstract]                        
Issued shares of restricted common stock                       7,724,000
Maximum additional shares                       7,500,000
Additional shares issued pursuant to foregoing                       607,396
Shares of common stock issued         455,000   1,018,356 500,000 455,000 112,500 13,914  
Par value per share of common stock issued         $ 1.00   $ 0.001 $ 0.001 $ 0.001      
Purchase price per share of common stock issued               $ 0.50 $ 1.00      
Issued warrant to holder, to purchase common shares             500,000          
Exercise price per share of warrant             $ 1.00          
Aggregate Units sold to accredited investors           1,300,000            
Aggregate Units sold to accredited investors, per Unit           $ 0.50            
Four-year warrant to purchase common stock, exercise price           $ 1.00            
Cancelled shares of common stock to Dr. Nian Wu 6,650,000                      
Issued shares of common stock upon cashless exercise of warrants   7,650,000 2,400,000 2,636,804                
Warrant to purchase shares upon cashless exercise   8,500,000 2,750,000 3,000,000